Studying the Effect of Glycosylation towards SARS-CoV-2 Spike RBD and ACE2 Interaction by Native Mass Spectrometry

Studying the Effect of Glycosylation towards SARS-CoV-2 Spike RBD and ACE2 Interaction by Native Mass Spectrometry

The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has serious consequences on global public health and social development. The binding of receptor binding domain (RBD) of spike protein to angiotensin converting enzyme 2 (ACE2)...

Full description

Bibliographic Details
Main Author:	LUO Yu-xiang;HUANG Jing;LI Hui-lin
Format:	Article
Language:	English
Published:	Editorial Board of Journal of Chinese Mass Spectrometry Society 2022-11-01
Series:	Zhipu Xuebao
Subjects:	covid-19 spike protein receptor binding domain (rbd) angiotensin converting enzyme 2 (ace2) glycoprotein n-glycosidase f native mass spectrometry
Online Access:	http://www.jcmss.com.cn/CN/article/openArticlePDF.jsp?attachType=PDF&id=3106

Similar Items

Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2
by: Arun Bahadur Gurung, et al.
Published: (2021-02-01)

Recombinant ACE2 protein protects against acute lung injury induced by SARS-CoV-2 spike RBD protein
by: Lingbing Zhang, et al.
Published: (2022-06-01)

Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding
by: Abdullah Hoter, et al.
Published: (2022-05-01)

A Suitable Membrane Distance Regulated by the RBD_ACE2 Interaction is Critical for SARS‐CoV‐2 Spike‐Mediated Viral Invasion
by: Mengdan Wu, et al.
Published: (2023-10-01)

Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex
by: Wai-Yim Ching, et al.
Published: (2022-09-01)

Structure-Based Virtual Screening and Identification of Potential Inhibitors of SARS-CoV-2 S-RBD and ACE2 Interaction
by: Jiacheng Xiong, et al.
Published: (2021-09-01)

Antigenicity of the Mu (B.1.621) and A.2.5 SARS-CoV-2 Spikes
by: Debashree Chatterjee, et al.
Published: (2022-01-01)

Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2
by: Raymond Rowland, et al.
Published: (2021-10-01)

Electrostatic Interactions Are the Primary Determinant of the Binding Affinity of SARS-CoV-2 Spike RBD to ACE2: A Computational Case Study of Omicron Variants
by: Peng Sang, et al.
Published: (2022-11-01)

Structural and functional insights into the major mutations of SARS-CoV-2 Spike RBD and its interaction with human ACE2 receptor
by: Arun Bahadur Gurung, et al.
Published: (2022-02-01)

The Development of Pharmacophore Models for the Search of New Natural Inhibitors of SARS-CoV-2 Spike RBD–ACE2 Binding Interface
by: Valentin A. Semenov, et al.
Published: (2022-12-01)

Global conserved RBD fraction of SARS-CoV-2 S-protein with T500S mutation in silico significantly blocks ACE2 and rejects viral spike
by: Amrita Banerjee, et al.
Published: (2022-02-01)

Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2
by: Shang Yu Gong, et al.
Published: (2022-09-01)

Glycyrrhizin Inhibits SARS-CoV-2 Entry into Cells by Targeting ACE2
by: Ming-Feng He, et al.
Published: (2022-10-01)

Understanding the pivotal roles of ACE2 in SARS-CoV-2 infection: from structure/function to therapeutic implication
by: Amir Pouremamali, et al.
Published: (2022-06-01)

Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2
by: Yixin Xie, et al.
Published: (2020-12-01)

Bergamottin and PAP-1 Induced ACE2 Degradation to Alleviate Infection of SARS-CoV-2
by: Mengjia Li, et al.
Published: (2022-10-01)

Thymosin-α1 binds with ACE and downregulates the expression of ACE2 in human respiratory epithelia
by: Yu-Hang Zhang, et al.
Published: (2022-02-01)

Role of tannic acid against SARS-cov-2 cell entry by targeting the interface region between S-protein-RBD and human ACE2
by: Xi Chen, et al.
Published: (2022-08-01)

A novel screening strategy of anti-SARS-CoV-2 drugs via blocking interaction between Spike RBD and ACE2
by: Xiaoning Wang, et al.
Published: (2021-02-01)

Characterization of Critical Determinants of ACE2–SARS CoV-2 RBD Interaction
by: Emily E. F. Brown, et al.
Published: (2021-02-01)

In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
by: Divya M. Teli, et al.
Published: (2021-01-01)

Inhibitors of the RBD-ACE-2 Found among a Wide Range of Dyes by the Immunoassay Method
by: Ekaterina D. Mordvinova, et al.
Published: (2023-02-01)

Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2Research in context
by: Annarita Miluzio, et al.
Published: (2023-01-01)

Lactoferrin Inhibition of the Complex Formation between ACE2 Receptor and SARS CoV-2 Recognition Binding Domain
by: Roberta Piacentini, et al.
Published: (2022-05-01)

Binding affinity between coronavirus spike protein and human ACE2 receptor
by: Marcus Ho-Hin Shum, et al.
Published: (2024-12-01)

Ultrafast Detection of SARS-CoV-2 Spike Protein (S) and Receptor-Binding Domain (RBD) in Saliva Using Surface-Enhanced Raman Spectroscopy
by: Mohammed Ba Abdullah, et al.
Published: (2022-05-01)

Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein to the Human Angiotensin-Converting Enzyme 2 Receptor and to Neutralizing Biomolecules Based on Computer Simulations
by: Damiano Buratto, et al.
Published: (2021-11-01)

Evaluating the Spike–hACE2 interactions in the wild type and variants of concern of SARS -CoV-2 at different temperatures
by: Nabanita Mandal, et al.
Published: (2024-01-01)

Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein
by: Qizhong Lu, et al.
Published: (2021-01-01)

Structural analysis of a simplified model reproducing SARS-CoV-2 S RBD/ACE2 binding site
by: Michela Buonocore, et al.
Published: (2022-11-01)

ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
by: Federica Saponaro, et al.
Published: (2020-09-01)

Structural Dissection of Viral Spike-Protein Binding of SARS-CoV-2 and SARS-CoV-1 to the Human Angiotensin-Converting Enzyme 2 (ACE2) as Cellular Receptor
by: Deborah Giordano, et al.
Published: (2021-08-01)

Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
by: Guillaume Beaudoin-Bussières, et al.
Published: (2020-10-01)

Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages
by: Umesh Kalathiya, et al.
Published: (2021-02-01)

Simultaneous Measurement of IgM and IgG Antibodies to SARS-CoV-2 Spike, RBD, and Nucleocapsid Multiplexed in a Single Assay on the xMAP INTELLIFLEX DR-SE Flow Analyzer
by: Andrew Cameron, et al.
Published: (2022-04-01)

Distinct Conformations of SARS-CoV-2 Omicron Spike Protein and Its Interaction with ACE2 and Antibody
by: Myeongsang Lee, et al.
Published: (2023-02-01)

The Increased Amyloidogenicity of Spike RBD and pH-Dependent Binding to ACE2 May Contribute to the Transmissibility and Pathogenic Properties of SARS-CoV-2 Omicron as Suggested by In Silico Study
by: Anna Y. Aksenova, et al.
Published: (2022-11-01)

Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries
by: Alon Ben David, et al.
Published: (2021-05-01)

Predictive Models of within- and between-Species SARS-CoV-2 Transmissibility
by: Ricardo Soares, et al.
Published: (2022-07-01)